SI0804234T1 - Vaccine adjuvant - Google Patents

Vaccine adjuvant

Info

Publication number
SI0804234T1
SI0804234T1 SI9530216T SI9530216T SI0804234T1 SI 0804234 T1 SI0804234 T1 SI 0804234T1 SI 9530216 T SI9530216 T SI 9530216T SI 9530216 T SI9530216 T SI 9530216T SI 0804234 T1 SI0804234 T1 SI 0804234T1
Authority
SI
Slovenia
Prior art keywords
adjuvants
repeating units
vaccine adjuvant
constitutive repeating
constitutive
Prior art date
Application number
SI9530216T
Other languages
English (en)
Slovenian (sl)
Inventor
Luuk Hilgers
Michel Strebelle
Original Assignee
Dimminaco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco Ag filed Critical Dimminaco Ag
Publication of SI0804234T1 publication Critical patent/SI0804234T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Devices For Use In Laboratory Experiments (AREA)
SI9530216T 1994-12-27 1995-12-21 Vaccine adjuvant SI0804234T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9401173A BE1008977A5 (fr) 1994-12-27 1994-12-27 Adjuvants pour vaccins.
PCT/BE1995/000118 WO1996020007A1 (fr) 1994-12-27 1995-12-21 Adjuvants pour vaccins
EP95942006A EP0804234B1 (fr) 1994-12-27 1995-12-21 Adjuvant pour vaccins

Publications (1)

Publication Number Publication Date
SI0804234T1 true SI0804234T1 (en) 1999-08-31

Family

ID=3888559

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530216T SI0804234T1 (en) 1994-12-27 1995-12-21 Vaccine adjuvant

Country Status (15)

Country Link
US (1) US6340464B1 (pt)
EP (1) EP0804234B1 (pt)
JP (1) JP3817655B2 (pt)
CN (1) CN1087177C (pt)
AT (1) ATE180676T1 (pt)
AU (1) AU713660B2 (pt)
BE (1) BE1008977A5 (pt)
BR (1) BR9510286A (pt)
CA (1) CA2208860C (pt)
DE (1) DE69510089T2 (pt)
DK (1) DK0804234T3 (pt)
ES (1) ES2131879T3 (pt)
GR (1) GR3031103T3 (pt)
SI (1) SI0804234T1 (pt)
WO (1) WO1996020007A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
JP2018020962A (ja) * 2014-12-08 2018-02-08 エヌエーアイ株式会社 新規アジュバント
KR20190044052A (ko) * 2016-06-17 2019-04-29 메리얼 인코포레이티드 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형
CN110404064B (zh) * 2018-04-27 2023-06-16 洛阳赛威生物科技有限公司 一种禽用佐剂组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE161050C (pt) *
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3790655A (en) * 1971-03-02 1974-02-05 E B & A C Whiting Co Method for commingling and orienting colored sets of thermoplastic filaments
US3920811A (en) * 1972-12-22 1975-11-18 Cutter Lab Adjuvant compositions
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US5047238A (en) * 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
EP0273512B1 (en) * 1986-12-19 1991-02-27 Duphar International Research B.V Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
US5565209A (en) * 1987-03-17 1996-10-15 Akzo Nobel N.V. Adjuvant mixture
DE3875762T2 (de) * 1987-03-17 1993-05-13 Akzo Nv Adjuvanzienmischung.
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
ZA929870B (en) * 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
RU2137767C1 (ru) * 1994-04-22 1999-09-20 Сумитомо Кемикал Компани, Лимитед Эфирные соединения и средство для борьбы с вредными насекомыми

Also Published As

Publication number Publication date
JP3817655B2 (ja) 2006-09-06
CA2208860A1 (en) 1996-07-04
DK0804234T3 (da) 1999-11-15
AU713660B2 (en) 1999-12-09
CN1171053A (zh) 1998-01-21
WO1996020007A1 (fr) 1996-07-04
CN1087177C (zh) 2002-07-10
ES2131879T3 (es) 1999-08-01
GR3031103T3 (en) 1999-12-31
DE69510089D1 (en) 1999-07-08
JPH11502191A (ja) 1999-02-23
AU4324796A (en) 1996-07-19
MX9704823A (es) 1998-06-30
US6340464B1 (en) 2002-01-22
EP0804234B1 (fr) 1999-06-02
CA2208860C (en) 2009-03-17
EP0804234A1 (fr) 1997-11-05
ATE180676T1 (de) 1999-06-15
DE69510089T2 (de) 1999-09-23
BR9510286A (pt) 1997-11-11
BE1008977A5 (fr) 1996-10-01

Similar Documents

Publication Publication Date Title
DE69428795D1 (de) Phosphazene und polyelektrolyte als immunadjuvantien
EP0269926A3 (en) Lens usable in the ultraviolet
TW284813B (pt)
EP0657478A3 (en) Process for the preparation of water-soluble polymer dispersions.
GB9811810D0 (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
DE68910174T2 (de) Druckdichte Steckkupplung.
AU5543294A (en) Submicron emulsions as vaccine adjuvants
EP0718364A4 (en) AQUEOUS FLUOROPOLYMER EMULSION AND METHOD FOR THE PRODUCTION THEREOF
AUPM612494A0 (en) Treatment or prevention of helicobacter infection
NO972219D0 (no) Immunogenpreparater
SI0804234T1 (en) Vaccine adjuvant
AU4015493A (en) Process for preparing polysuccinimides from aspartic acid
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
AU5297999A (en) Use of a composition
AU4276689A (en) The use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
HUT77018A (hu) Eljárás terpolimerek előállítására
AU8113694A (en) Water treatment system comprising water-soluble glass
GB2275472A (en) DNA fragment comprising a gene encoding ethylene forming enzyme of bacteria and the use therof
AU5435390A (en) High calcium chemically defined culture medium
AU8085691A (en) Activation of polysaccharide hydrolase
AU7702791A (en) Stable acrylic copolymer dispersions
CA2066805A1 (en) Polymers and their preparation
AU1081283A (en) Ozone inactivated organisms as vaccines
AU2053192A (en) Aqueous polymer dispersions

Legal Events

Date Code Title Description
SP73 Change of data on owner

Owner name: PFIZER AG; CH

Effective date: 20101209

SP73 Change of data on owner

Owner name: ZOETIS SCHWEIZ GMBH; CH

Effective date: 20130801